Brief: Unicycive Announces Full Year 2022 Financial Results And Provides Business Update

Unicycive Therapeutics

31/03/2023 12:08

March 31 (Reuters) - Unicycive Therapeutics Inc
 UNCY.O :
    * UNICYCIVE ANNOUNCES FULL YEAR 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * ON TRACK TO FILE NEW DRUG APPLICATION WITH U.S. FDA IN
MID-2023
WITH POTENTIAL FOR APPROVAL AND LAUNCH IN 2024
    * FY LOSS PER SHARE $1.20
    * AS OF DEC 31, 2022, CASH AND CASH EQUIVALENTS TOTALED $0.5
MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7l6hpz 
Further company coverage:  UNCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))